Immune response to Pneumococcal Vaccination in Ageing population

This study is characterising the immune response to Pneumococcal vaccination in older people to inform a clinical trial assessing whether granulocyte-macrophage colony-stimulating factor (GM-CSF) can augment vaccine efficacy.

This study is funded by MRC.